Physician profile
William Hixson
NPI 1932183217
$9,799.12
in general payments reported to CMS, 2019-2025
67 companies · $2,275 in 2025
The $2,275 reported for 2025 was more than what 91% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $534 · 2020: $521 · 2021: $1,038 · 2022: $1,537 · 2023: $1,834 · 2024: $2,060 · 2025: $2,275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,169.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,168.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,015.95 | 2019-2025 | Piqray, Kisqali |
| Astrazeneca Pharmaceuticals LP | $856.27 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Merck Sharp & Dohme LLC | $609.12 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Regeneron Healthcare Solutions, INC. | $551.97 | 2022-2025 | Libtayo, Lynozyfic |
| Janssen Biotech, INC. | $517.05 | 2019-2025 | Tecvayli, Darzalex, Erleada |
| Incyte Corporation | $433.52 | 2020-2025 | Monjuvi, Jakafi, Zynyz |
| Lilly USA, LLC | $428.20 | 2020-2025 | Jaypirca, Verzenio, Retevmo |
| Eisai INC. | $386.67 | 2020-2025 | |
| Amgen INC. | $367.08 | 2020-2023 | Nplate, Xgeva, Vectibix |
| E.R. Squibb & Sons, L.L.C. | $272.48 | 2022-2025 | Opdivo |
| Daiichi Sankyo INC. | $239.12 | 2022-2025 | Enhertu, Datroway |
| Exelixis INC. | $230.16 | 2019-2025 | Cabometyx |
| Abbvie INC. | $229.55 | 2019-2025 | |
| Blueprint Medicines Corporation | $223.00 | 2020-2025 | Ayvakit |
| Genzyme Corporation | $222.98 | 2022-2025 |
Show all 67 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $178.87 | 2023-2025 | Polivy, Columvi, Lunsumio |
| Bayer Healthcare Pharmaceuticals INC. | $175.36 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $170.32 | 2024-2025 | Monoferric, Cosela |
| Seagen INC. | $161.70 | 2021-2023 | Adcetris |
| Pfizer INC. | $160.95 | 2019-2025 | |
| Pharmaessentia USA Corporation | $146.12 | 2023-2025 | Besremi |
| Astellas Pharma US INC | $144.66 | 2019-2025 | Vyloy, Xospata, Padcev |
| Stemline Therapeutics INC. | $126.67 | 2023-2025 | Orserdu |
| Boston Scientific Corporation | $125.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $118.80 | 2022-2025 | Ninlaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $94.51 | 2023-2025 | Gilotrif |
| Glaxosmithkline, LLC. | $85.11 | 2020-2024 | Zejula, Jemperli, Ojjaara |
| Novocure INC. | $83.57 | 2020-2025 | Optune Lua (Novottf-200t) |
| Sumitomo Pharma America, INC. | $80.50 | 2023-2025 | Orgovyx |
| Ethicon INC. | $78.12 | 2021 | |
| Aveo Pharmaceuticals, INC. | $76.44 | 2021-2025 | Fotivda |
| Genmab U.S., INC. | $72.05 | 2024-2025 | Epkinly |
| Beigene USA, INC. | $65.66 | 2022-2025 | Brukinsa |
| Tempus Ai, INC | $63.44 | 2024 | |
| Progenics Pharmaceuticals, INC. | $58.01 | 2023-2025 | Pylarify |
| Ge Healthcare | $55.87 | 2019 | |
| Myovant Sciences INC. | $54.08 | 2021-2022 | |
| Beone Medicines USA, INC. | $51.35 | 2025 | Brukinsa, Tevimbra |
| Pharmacyclics LLC, An Abbvie Company | $46.63 | 2023 | Imbruvica |
| Alexion Pharmaceuticals, INC. | $43.04 | 2023-2024 | Ultomiris |
| Apellis Pharmaceuticals, INC. | $42.18 | 2023-2024 | Empaveli |
| Adaptive Biotechnologies Corporation | $39.79 | 2024-2025 | Clonoseq |
| Agios Pharmaceuticals, INC. | $38.02 | 2024-2025 | Pyrukynd |
| Sobi, INC | $37.69 | 2022-2023 | |
| Ipsen Biopharmaceuticals, INC | $36.67 | 2024-2025 | Onivyde |
| Celgene Corporation | $36.66 | 2019-2025 | Opdualag |
| Puma Biotechnology, INC. | $35.72 | 2022-2024 | |
| Dendreon Pharmaceuticals LLC | $34.76 | 2024 | Provenge |
| Immunogen, INC. | $33.92 | 2023 | Elahere |
| Mirati Therapeutics, INC. | $32.57 | 2023-2024 | Krazati |
| Coherus Oncology, INC. | $32.11 | 2022-2023 | |
| Myriad Genetic Laboratories, INC. | $29.78 | 2021-2024 | Myrisk |
| Servier Pharmaceuticals LLC | $27.92 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $22.78 | 2022 | |
| Pharming Healthcare, INC. | $22.69 | 2023 | Ruconest |
| Karyopharm Therapeutics INC. | $21.28 | 2022 | |
| Springworks Therapeutics, INC. | $20.80 | 2025 | Ogsiveo |
| Caris Mpi, INC. | $20.65 | 2025 | Mi Cancer Seek |
| Paratek Pharmaceuticals, INC. | $19.25 | 2021 | |
| Array Biopharma INC | $19.22 | 2023 | Mektovi, Xalkori, Lorbrena |
| Azurity Pharmaceuticals, INC. | $17.53 | 2025 | Danziten |
| Tg Therapeutics, INC. | $16.58 | 2021 | |
| Amag Pharmaceuticals, INC. | $14.22 | 2019 | |
| Clovis Oncology, INC. | $13.24 | 2022 | |
| Rigel Pharmaceuticals, INC. | $12.14 | 2022 | |
| Medtronic USA, INC. | $11.32 | 2020 | |
| Brainlab, INC. | $9.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Hixson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.